Liaison(s): David Rozzell
BioCatalytics produces a comprehensive array of enzymes useful in the synthesis of new drugs. These enzymes may also have applications as diagnostics in food and environmental safety testing, clinical diagnostics, and research. In 2004, BioCatalytics created a small group of diagnostic enzyme products for the purpose of evaluating the sales potential for these applications. The KGI team conducted a market segmentation analysis to assess potential customer demands and current competitors in the diagnostic enzyme arena. The project also included assay development and construction of manufacturing protocols for a few identified products. The team analyzed regulatory and manufacturing issues associated with launching diagnostic enzyme products.